Haier Biomedical Debuts Cold Storage Products
Analysis based on 7 articles · First reported Jun 25, 2026 · Last updated Jun 25, 2026
The launch of innovative low-carbon cold storage products by Haier Biomedical is expected to positively impact the biotechnology and pharmaceutical industries by providing advanced solutions for sample preservation. This could lead to increased adoption of Haier Biomedical's products globally, potentially boosting its stock performance and market share.
Haier Biomedical, a global leader in life sciences and medical solutions, simultaneously debuted innovative automated low-carbon cold storage products at Europe Biobank Week 2026 in Prague and Interphex Week Tokyo 2026. The company launched the HAB80-60KA/KB automated ultra-low temperature sample storage system for Europe's biobank needs and the DWL368BPST ultra-low temperature freezer specifically for space-constrained laboratories in Japan. These new products emphasize low-carbon design, modular flexibility, AI-driven monitoring, and enhanced safety features. Haier Biomedical also fostered academic collaborations, such as with Professor Marco Agostini from the University of Padua, to strengthen its global market presence through localized R&D and deep-rooted local service.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard